Strickland Kyle C, Vivero Marina, Jo Vickie Y, Lowe Alarice C, Hollowell Monica, Qian Xiaohua, Wieczorek Tad J, French Christopher A, Teot Lisa A, Sadow Peter M, Alexander Erik K, Cibas Edmund S, Barletta Justine A, Krane Jeffrey F
1 Department of Pathology, Brigham and Women's Hospital , Harvard Medical School, Boston, Massachusetts.
2 Department of Pathology, Massachusetts General Hospital , Harvard Medical School, Boston, Massachusetts.
Thyroid. 2016 Oct;26(10):1466-1471. doi: 10.1089/thy.2016.0280. Epub 2016 Sep 8.
The term noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has been proposed to replace noninvasive follicular variant of papillary thyroid carcinoma (FVPTC) in recognition of the indolent behavior of this tumor. The ability to differentiate NIFTP from classical papillary thyroid carcinoma (cPTC) by fine-needle aspiration (FNA) would facilitate conservative management for NIFTP. The aim of this study was to determine if NIFTP can be distinguished prospectively from cPTC.
From June 2015 to January 2016, thyroid FNAs with a diagnosis of "malignant" or "suspicious for malignancy" were prospectively scored for features associated with NIFTP/FVPTC (microfollicular architecture) or cPTC (papillae, psammomatous calcifications, sheet-like architecture, and nuclear pseudoinclusions) and categorized as NIFTP/FVPTC, cPTC, or indeterminate. Results were correlated with subsequent histologic diagnoses.
The study included 52 patients with 56 resected nodules with a cytologic diagnosis of "malignant" (43/56) or "suspicious for malignancy" (13/56). Forty-nine patients (94%) underwent initial total thyroidectomy. Histopathologic diagnoses included 42 cPTC, 8 NIFTP, 3 invasive FVPTC, 2 follicular adenomas, and 1 poorly differentiated carcinoma. Excluding 7 indeterminate cases, 89% (8/9) of nodules classified as NIFTP/FVPTC on FNA demonstrated follicular-patterned lesions on histology (5 NIFTP, 1 invasive FVPTC, 2 follicular adenomas). Cytopathologists prospectively identified cPTC in 95% (38/40) of cases.
In thyroid FNAs with cytologic features concerning for PTC, NIFTP/FVPTC can be distinguished from cPTC in most cases by assessing a limited number of features. Therefore, it is both feasible and appropriate to attempt to separate NIFTP/FVPTC from cPTC on FNA to promote appropriate clinical management.
提出术语“具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)”以取代甲状腺乳头状癌滤泡性变异型(FVPTC),以认识到该肿瘤的惰性生物学行为。通过细针穿刺抽吸活检(FNA)将NIFTP与经典甲状腺乳头状癌(cPTC)区分开来的能力将有助于对NIFTP进行保守治疗。本研究的目的是确定能否前瞻性地将NIFTP与cPTC区分开来。
2015年6月至2016年1月,对诊断为“恶性”或“可疑恶性”的甲状腺FNA进行前瞻性评分,评估与NIFTP/FVPTC相关的特征(微滤泡结构)或cPTC相关的特征(乳头、砂粒体钙化、片状结构和核假包涵体),并分类为NIFTP/FVPTC、cPTC或不能确定。结果与随后的组织学诊断进行相关性分析。
该研究纳入了52例患者,共56个切除结节,细胞学诊断为“恶性”(43/56)或“可疑恶性”(13/56)。49例患者(94%)接受了初次全甲状腺切除术。组织病理学诊断包括42例cPTC、8例NIFTP、3例侵袭性FVPTC、2例滤泡性腺瘤和1例低分化癌。排除7例不能确定的病例,FNA分类为NIFTP/FVPTC的结节中,89%(8/9)在组织学上表现为滤泡样病变(5例NIFTP、1例侵袭性FVPTC、2例滤泡性腺瘤)。细胞病理学家前瞻性地在95%(38/40)的病例中识别出cPTC。
在具有PTC细胞学特征的甲状腺FNA中,通过评估有限数量的特征,在大多数情况下可以将NIFTP/FVPTC与cPTC区分开来。因此,在FNA上尝试将NIFTP/FVPTC与cPTC区分开来以促进适当的临床管理是可行且合适的。